Pegzilarginase-nbln vs Semax

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Pegzilarginase-nbln is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement.

This page compares Pegzilarginase-nbln and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Pegzilarginase-nblnSemax
CategoryWeight Management & MetabolicCognitive Enhancement
Regulatory status (US)FDA approvedCompounding (Rx) — Apr 2026
Typical dosage300-600 mcg
Frequencydaily
Reported benefitsEnhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience
Reported side effectsGenerally safe. Possible: overstimulation, sleep disturbances if taken late

Key differences

Primary use. Pegzilarginase-nbln is categorised under Weight Management & Metabolic, while Semax falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Pegzilarginase-nbln: FDA-approved. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Typical dosing for Pegzilarginase-nbln is not catalogued. Semax is typically dosed at 300-600 mcg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Pegzilarginase-nbln and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Pegzilarginase-nbln and Semax?
Pegzilarginase-nbln is primarily a weight management & metabolic peptide, while Semax is used for cognitive enhancement. Pegzilarginase-nbln is FDA-approved for one or more indications, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
What is Pegzilarginase-nbln used for?
PEGylated recombinant arginase enzyme for Arginase 1 Deficiency. FDA approved February 23, 2026.
What is Semax used for?
Cognitive enhancement, focus, memory.
Can you take Pegzilarginase-nbln and Semax together?
Some users combine peptides within a single protocol, but stacking Pegzilarginase-nbln and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Pegzilarginase-nbln or Semax FDA-approved?
Pegzilarginase-nbln is FDA-approved for one or more indications. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).

Read the full articles

  • Pegzilarginase-nbln — full monograph: mechanism, research, dosing & references
  • Semax — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

Pegzilarginase-nbln compared across categories

← All peptide comparisons